Zyban not a heart risk but ineffective as smoking cessation aid, says study

The story is here. Researchers working with a group of patients with acute coronary syndrome found no significant difference between abstinence rates at one year between patients taking the drug and those on a placebo. They found no significant difference in coronary events between the two groups either.

As we discovered yesterday, even medical attention is turning to the idea that willpower works best:

Varenicline has been shown to modestly increase the chances of a successful quit attempt, compared to unassisted smoking cessation attempts. But overall, the majority of smokers who quit do so without any pharmaceutical assistance at all.